Biosynthesis of the Allylmalonyl-CoA Extender Unit for the FK506 Polyketide Synthase Proceeds Through a Dedicated Polyketide Synthase and Facilitates the Mutasynthesis of Analogues
SangJoon Mo,Dong Hwan Kim,Jong Hyun Lee,Je Won Park,Devi B. Basnet,Yeon Hee Ban,Young Ji Yoo,Shu-wei Chen,Sung Ryeol Park,Eun Ae Choi,Eunji Kim,Ying-Yu Jin,Sung-Kwon Lee,Ju Yeol Park,Yuan Liu,Mi Ok Lee,Keum Soon Lee,Sang Jun Kim,Dooil Kim,Byoung Chul Park,Sang-gi Lee,Ho Jeong Kwon,Joo-Won Suh,Bradley S. Moore,Si-Kyu Lim,Yeo Joon Yoon
DOI: https://doi.org/10.1021/ja108399b
IF: 15
2010-01-01
Journal of the American Chemical Society
Abstract:The allyl moiety of the immunosuppressive agent FK506 is structurally unique among polyketides and critical for its potent biological activity. Here, we detail the biosynthetic pathway to allylmalonyl-coenzyme A (CoA), from which the FK506 allyl group is derived, based on a comprehensive chemical, biochemical, and genetic interrogation of three FK506 gene clusters. A discrete polyketide synthase (PKS) with noncanonical domain architecture presumably in coordination with the fatty acid synthase pathway of the host catalyzes a multistep enzymatic reaction to allylmalonyl-CoA via trans-2-pentenyl-acyl carrier protein. Characterization of this discrete pathway facilitated the engineered biosynthesis of novel allyl group-modified FK506 analogues, 36-fluoro-FK520 and 36-methyl-FK506, the latter of which exhibits improved neurite outgrowth activity. This unique feature of FK506 biosynthesis, in which a dedicated PKS provides an atypical extender unit for the main modular PKS, illuminates a new strategy for the combinatorial biosynthesis of designer macrolide scaffolds as well as FK506 analogues.